drugset / Trial / NCT02940314
Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the safety and pharmacokinetic characteristics after administration of HIP1503 and HGP1103 in healthy male volunteers.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HGP1103 | Unknown | 10 mg | — |
| Subject | HIP1503 | Unknown | 10.66 mg | — |